Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby group said on Thursday after business leaders, including CEO of obesity drugmaker Novo Nordisk,

Trump added Denmark to his growing list of tariff targets — including Canada, Mexico and China — as he has increasingly spoken of the U.S. taking Greenland off Denmark’s hands. Danish multinational pharmaceutical giant Novo Nordisk is the sole owner ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.

A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the competitive field.

With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). A Scandinavian economic behemoth ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated prices for Ozempic, Wegovy, and Rybelsus will be. In Medicare's negotiations for 2026, the new prices achieved an average of 22% savings.

Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.

The dollar dropped to a one-month low after President Donald Trump appeared to soften his approach toward tariffs on China. Stock futures fluctuated after the S&P 500 scaled a fresh peak.

US stocks closed lower afer the S&P 500 touched an intraday record high early in the day. As tariff worries eased, mixed company news took focus.

LONDON (Reuters) - It's a big week ahead as the U.S. Federal Reserve, European Central Bank and Bank of Canada hold their first meetings of 2025. Into the mix go earnings from heavyweights including Apple (NASDAQ: AAPL) and Tesla (NASDAQ: TSLA ), and likely market spikes from comments by new U.S. President Donald Trump - especially any on tariffs.

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger.

The three laggards were energy stocks, off 1.1%, industrials, sliding 0.5%, and consumer staples, falling 0.4%. The S&P 500 reached new records on Friday as optimism around the start of President Donald Trump’s term continued.